Wendy Lee

RAF KINASE INHIBITORS

INHIBITION OF P38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS

Aryl ureas as kinase inhibitors

Inhibition Of Raf Kinase Using Substituted Heterocyclic Ureas

INHIBITION OF P38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS

Aryl ureas as kinase inhibitors

SUBSTITUTED PYRIDINES AND PYRIDAZINES WITH ANGIOGENESIS INHIBITING ACTIVITY

Substituted pyridines and pyridazines with angiogenesis inhibiting activity

Substituted pyrimidine derivatives useful in the treatment of cancer and other disorders

SUBSTITUTED PYRIDINE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER AND OTHER DISORDERS

Raf Kinase Inhibitors

Cyanopyridine derivatives useful in the treatment of cancer and other disorders

Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders

INHIBITION OF RAF KINASE USING SUBSTITUTED HETEROCYCLIC UREAS

Fused tricyclic heterocycles useful for treating hyper-proliferative disorders

Raf kinase inhibitors

2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists

Fused tricyclic heterocycles useful for treating hyper-proliferative disorders

2,6-substituted chroman derivatives useful as beta-3 adrenoreceptor agonists

Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders

Substituted pyridazines and fused pyridazines with angiogenesis inhibiting activity

Bicyclic urea derivatives useful in the treatment of cancer and other disorders